Microarray Analysis of Gene Expression in Prostate Tissues

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Active, Not Recruiting to Completed
    • Primary and study completion dates changed from estimate of Dec 2030 to Apr 21, 2009
    • Collaborators: 2 to 3
    v18
  2. Enrollment target: estimated 2000 to confirmed 867v17
  3. Re-verified, no change to tracked fieldsv16
  4. Primary and study completion dates: Dec 2021 to Dec 2030
    • Start date: Apr 1999 to Apr 6, 1999
    v15
  5. Collaborators expanded, about 9 wordsv14
Show 12 earlier versionsHide 12 earlier versions
  1. Re-verified, no change to tracked fieldsv13
  2. Primary and study completion dates: Dec 2017 to Dec 2021v12
  3. Study Status, Outcome Measuresv11
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  5. Re-verified, no change to tracked fieldsv9
  6. Enrollment target: 800 to 2000
    • Primary and study completion dates: Dec 2011 to Dec 2017
    v8
  7. Primary and study completion dates: Dec 2011
    • Collaborators shortened, about 5 words
    v7
  8. Re-verified, no change to tracked fieldsv6
  9. Eligibility criteria expanded, about 9 wordsv5
  10. 3 versions Re-verified since Mar 27, 2006, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate gene expression profiles and biologic features of prostate tissue and how they relate to prostate cancer development and growth.
Trial Details
NCT Number NCT00186368
Lead Sponsor Stanford University
Collaborators: National Institutes of Health (NIH), University of Wisconsin, Madison, National Cancer Institute (NCI)
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 867 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov